COMPANY PROFILE · UPDATED 18 NOV 2025

Tome Biosciences

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology. Using CRISPR, its technologies allow them to insert any genetic sequence of any size at any location into any genome.

tome.bio ↗

This profile is unclaimed — do you work here? Claim it

Claim it →

Founded: 2021
Headcount: 91
Open roles: 0
Last raised: Series A · Sign in to view

LEADERSHIP

Founders & key people

Omar Abudayyeh

Researcher

Massachusetts Institute of Technology (MIT)Sherlock BiosciencesBroad InstituteModalystNotarizeProof DiagnosticsHarvard Medical SchoolMassachusetts Institute of Technology (MIT)

Jonathan Gootenberg

Researcher

Massachusetts Institute of Technology (MIT)Sherlock BiosciencesBroad InstituteNotarizeProof DiagnosticsHarvard UniversityHarvard UniversityMassachusetts Institute of Technology (MIT)

OPEN ROLES

Hiring at Tome Biosciences

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Categorized in

Industry

Healthcare & Biotech Biotech & Drug Discovery

Investors

Gv Andreessen Horowitz

Industries

Software Companies Medical Organizations Biotechnology Companies

Tech Stack

Mysql Php Wordpress

LOCATIONS

Where they work

Tome Biosciences Headquarters Location

100 Talcott Avenue, Watertown, MA, 02472

Loading map…